Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug toxicity and hormonal dysfunction.

M Eichelbaum

    Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Endocrine diseases alter organ function, significantly changing how the body processes drugs. Understanding these hormonal effects is crucial for safe and effective medication dosing to prevent toxicity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer.

    The pharmacogenomics journal·2014
    Same author

    CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.

    Clinical pharmacology and therapeutics·2013
    Same author

    [Pharmacogenetics: current state after 30 years of research].

    Deutsche medizinische Wochenschrift (1946)·2013
    Same author

    Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma.

    Clinical pharmacology and therapeutics·2011
    Same author

    X-ray-assisted formation of gold nanoparticles in soda lime silicate glass: suppressed Ostwald ripening.

    Physical review letters·2011
    Same author

    The impact of thyroid disease on the regulation, expression, and function of ABCB1 (MDR1/P glycoprotein) and consequences for the disposition of digoxin.

    Clinical pharmacology and therapeutics·2010
    Same journal

    Diversification in toxicology--man and environment. Proceedings of the 1997 EUROTOX Congress. Arhus, Denmark, June 25-28, 1997.

    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement·1998
    Same journal

    Comparison of GST theta activity in liver and kidney of four species.

    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement·1998
    Same journal

    Expression of xenobiotic-metabolizing cytochrome P450s in human pulmonary tissues.

    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement·1998
    Same journal

    Extrahepatic cytochrome P450: role in in situ toxicity and cell-specific hormone sensitivity.

    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement·1998
    Same journal

    The use of transgenic animals to assess the role of metabolism in target organ toxicity.

    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement·1998
    Same journal

    Population responses to contaminant exposure in marine animals: influences of genetic diversity measured as allozyme polymorphism.

    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement·1998
    See all related articles

    Area of Science:

    • Endocrinology
    • Pharmacology
    • Drug Metabolism

    Background:

    • Hormonal imbalances profoundly impact drug disposition.
    • Endocrine diseases cause widespread changes in organ function.
    • Altered organ function affects drug distribution, metabolism, and excretion.

    Purpose of the Study:

    • To highlight the impact of endocrine diseases on drug disposition.
    • To emphasize the necessity of considering organ function changes in dosage regimens.
    • To underscore the risk of drug toxicity if these factors are ignored.

    Main Methods:

    • Review of physiological changes in endocrine diseases.
    • Analysis of how these changes affect pharmacokinetic processes.
    • Correlation of altered drug disposition with potential toxicity.

    Related Experiment Videos

    Main Results:

    • Abnormal hormone levels significantly alter drug disposition.
    • Changes in organ function directly impact drug distribution, metabolism, and excretion.
    • Failure to account for these alterations can lead to adverse drug events.

    Conclusions:

    • Endocrine disease management requires careful consideration of drug disposition.
    • Dosage regimens must be individualized based on altered organ function.
    • Proactive adjustment of medication is essential to prevent drug toxicity in endocrine disorders.